Richard J. Ablin
Corporate Officer/Principal bei Tetragenex Pharmaceuticals, Inc.
Aktive Positionen von Richard J. Ablin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Tetragenex Pharmaceuticals, Inc.
 Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Corporate Officer/Principal | 05.02.2010 | - |
Karriereverlauf von Richard J. Ablin
Ehemalige bekannte Positionen von Richard J. Ablin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The State University of New York | Direktor/Vorstandsmitglied | 01.01.1989 | 01.01.1989 |
| Corporate Officer/Principal | 01.01.1989 | 01.01.1989 |
Ausbildung von Richard J. Ablin
| State University of New York at Buffalo | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Tetragenex Pharmaceuticals, Inc.
Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Health Technology |
- Börse
- Insiders
- Richard J. Ablin
- Erfahrung
